Study of dihydropteroate synthase (DHPS) gene mutations among isolates of Pneumocystis jiroveci

Indian Journal of Medical Research

Volumn 128, Issue 6, 2008, Pages 734-739

  Tyagi, A K ^a   Mirdha, B R ^a   Guleria, Randeep ^a   Mohan, Anant ^a   Luthra, Kalpana ^a   Singh, U B ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

DHPS PCR PCP; Pneumocystis jiroveci; RFLP

Indexed keywords

CLINDAMYCIN; COTRIMOXAZOLE; DIHYDROPTEROATE SYNTHASE; GLYCOPROTEIN; MAJOR SURGACE GLYCOPROTEIN; PRIMAQUINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CHILD; CODON; CONTROLLED STUDY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; FUNGAL EXAMINATION; FUNGAL GENETICS; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; GENE AMPLIFICATION; GENE LOCUS; GENE MUTATION; GENE TARGETING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; POINT MUTATION; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SILVER STAINING;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DIHYDROPTEROATE SYNTHASE; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; MUTATION; PNEUMOCYSTIS JIROVECII; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROSPECTIVE STUDIES;

EID: 61849116209     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Stansel JD, Huang L. Pneumocystis carinii pneumonia. In: Sande MA, Volberding PA, editors. The medical management of AIDS. Philadelphia: WB Saunders Co; 1996. p. 275-300.
2. Fisk DT, Meshnick S, Kazanjian PH. Pneumocystis carinii pneumonia in patients in the developing world who have acquired immunodeficiency syndrome. Clin Infect Dis 2003; 36: 70-8.
3. Stringer JR, Beard CB, Miller RF, Wakefield AE. A New Name ( Pneumocystis jiroveci) for Pneumocystis from humans. Emerg Infect Dis 2002; 8: 891-6.
4. Armstrong W, Meshnick S, Kazanjian P. Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in immunocompromised patients. Microbes Infect 2000; 2: 61-7.
5. Volpe F, Ballantine SP, Delves CJ. The multifunctional folic acid synthesis FAS gene of Pneumocystis carinii encodes dihydroneopterin aldolase, hydroxy methyl dihydroneopterin pyrophosphokinase and dihydropteroate synthase. Eur J Biochem 1993; 216: 449-58.
6. Helweg LJ, Benefield TL, Eugen OJ, Lundgren JD, Lundgren B. Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcomes of AIDS associated P. carinii pneumonia. Lancet 1999; 354: 1347-51.
7. Kazanjian P, Armstrong W, Hossler PA, Burman W, Richardson J, Lee CH, et al. Pneumocystis carinii mutations are associated with duration of sulfa or sulfone prophylaxis exposure in AIDS patients. J Infect Dis 2000; 182: 551-7.
8. Takahashi T, Hosoya N, Nakamura TN, Sakashita H, Kimura K, Ohnishi K, et al. Relationship between mutations in dihydropteroate synthase of Pneumocystis carinii f. Sp hominis isolates in Japan and resistance of sulfonamide therapy. J Clin Microbiol 2000; 38: 3161-4.
9. Visconti E, Ortona E, Men Carinii P, Margutti P, Marinoci S, Zolfo M, et al. Mutations in dihydropteroate synthase gene of Pneumocystis carinii in HIV patients with Pneumocystis carinii pneumonia. Int J Antimicrob Agent 2001; 18: 547-51.
10. Brooks DR, Wany P, Read M, Watkins WM, Sims DF, Hyde JE. Sequence variation of the hydroxy methyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfa. Eur J Biochem 1994; 224: 397-405.
11. Dallas WS, Gowen JE, Ray PH, Cox MJ, Dev LK. Cloning, sequencing and enhanced expression of the dihydropteroate synthase gene of Escherichia coli MC4 100. J Bacteriol 1992; 174: 5961-70.
12. Churukian CJ, Schenk EA. Rapid Grocott's methenamine silver nitrate method for fungi and Pneumocystis carinii. Am J Clin Path 1977; 68: 427-8.
13. Ng VL, Virani NA, Chaisson RE, Yajko DM, Sphar HT, Cabrian K, et al. Rapid detection of Pneumocystis carinii using a direct fluorescent monoclonal antibody stain. J Clin Microbiol 1990; 28: 2228-33.
14. Huang SN, Fisher SH, Shaughnessy E, Gill VJ, Masur H, Kovacs JA. Development of a PCR assay for diagnosis of P. carinii pneumonia based on amplification of multicopy Major Surface Glycoprotein gene family. Diagn Microbial Infect Dis 1999; 35: 27-32.
15. Helweg LJ, Jensen JS, Benfield T, Svendsen UG, Lundgren JD, Lundgren B. Diagnostic use of PCR for detection of Pneumocystis carinii in oral wash samples. J Clin Microbiol 1998; 36: 2068-72.
16. Helweg LJ, Skov JJ, Lundgren B. Non-invasive diagnosis of Pneumocystis carinii pneumonia by PCR on oral washes. Lancet 1997; 350: 1363.
17. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 1989; 339: 237-8.
18. Lopez P, Espinosa M, Greenberg B, Lacks SA. Sulfonamide resistance in Streptococcus pneumoniae: DNA sequence of the gene encoding dihydropteroate synthase and characterization of the enzyme. J Bacteriol 1987; 169: 4320-6.
19. Triglia T, Menting JG, Wilson C, Cowman AF. Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. Proc Natl Acad Sci USA 1997; 25: 13944-9.
20. Radstrom P, Fermer C, Kristiansen BE, Jenkins A, Skod O, Swedberg G. Transformational exchanges in the dihydropteroate synthase gene of Neisseria meningitidis; a novel mechanism for acquisition of sulfonamide resistance. J Bacteriol 1992; 20: 6386-93.
21. Lane BR, Ast JC, Hossler PA, Mindell DP, Barelerr MS, Smith JW. Dihydropteroate synthase polymorphism in Pneumocystis carinii. J Infect Dis 1997; 175: 482-5.
22. Kazanjian PH, Locke AB, Hossier PA, Lane BR, Bartlett MS, Smith JW, et al. Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failure in AIDS patients. AIDS 1998; 12: 873-8.
23. Mei Q, Gurunathan S, Masur H, Kovacs JA. Failure of cotrimoxazole in Pneumocystis carinii infection and mutations in dihydropteroate synthase gene. Lancet 1998; 351: 1631-2.
24. Huang L, Beard CB, Creasman J, Levy D, Duchin JS, Lee S, et al. Sulfa or sulfone prophylaxis and geographic region predict mutations in the Pneumocystis carinii dihydropteroate synthase gene. J Infect Dis 2000; 182: 1192-8.
25. Ma L, Borio L, Masur H, Kovacs JA. Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim - sulfamethoxazole or dapsone use. J Infect Dis 1999; 180: 1969-78.
26. Kazanjian PH, Fisk D, Armstrong W. Increase in prevalence of Pneumocystis carinii mutations in patients with AIDS and P. carinii pneumonia in the United States and China. J Infect Dis 2004; 189: 1684-7.
27. Helweg LJ, Tsolaki AG, Miller RF, Lundgren B, Wakefield AE. Clusters of Pneumocystis carinii pneumonia: analysis of person to person transmission by genotyping. Q J Med 1998; 91: 813-20.
28. Ma L, Kovacs JA, Cargnel A, Valerio A, Fantoni G, Atzori C. Mutations in the dihydropteroate synthase gene of human derived Pneumocystis carinii isolates from Italy are infrequent but correlate with prior sulfa prophylaxis. J Infect Dis 2002; 185: 1530-2.
29. Nahimana A, Rabodonirina M, Zanetti G. Association between a specific Pneumocystis jiroveci dihydropteroate synthase mutation and failure of pyrimethamine/sulfadoxine prophylaxis in human immunodeficiency virus positive and negative patients. J Infect Dis 2003; 188: 1017-23.
30. Wissmann G, Alvarez-Martinez MJ, Meshnick SR, Dihel AR, Prolla JC. Absence of dihydropteroate synthase mutations in Pneumocystis jiroveci from Brazilian AIDS patients. J Eukaryot Microbiol 2006; 53: 305-7.